Table 1 BMP methylation and k-ras mutation in NSCLC

From: Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer

 

BMP3B methylation

BMP6 methylation

Concurrent BMP3b and BMP6 methylation

 

NM a

M a

P -value

NM a

M a

P -value

NM a

M a

P -value

Overall prevalence in NSCLC (n (%))

68 (44%)

88 (56%)

 

96 (60%)

63 (40%)

    

k-ras mutation (codon 12)

 Not mutated (%)

62 (91)

69 (78)

 

82 (87)

49 (78)

 

93 (89)

30 (70)

 

 Mutated (%)

6 (9)

19 (22)

0.03b

12 (13)

14 (22)

0.12b

11 (11)

13 (30)

0.003b

  1. aNM=not methylated; M=methylated.
  2. bχ2 test.